BioLife Solutions, Inc.
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
104.59 |
97.76 |
114.86 |
142.12 |
171.89 |
206.21 |
Przychód Δ r/r |
0.00% |
-6.54% |
17.50% |
23.73% |
20.95% |
19.97% |
Przychód (min) |
80.86 |
93.74 |
112.01 |
141.66 |
167.79 |
201.29 |
Przychód (max) |
113.10 |
103.71 |
120.41 |
142.59 |
178.74 |
214.43 |
EBITDA (średnia) |
-11.87 |
-11.10 |
-13.04 |
-16.13 |
-19.51 |
-23.40 |
EBIT (średnia) |
-23.59 |
-22.05 |
-25.91 |
-32.06 |
-38.77 |
-46.52 |
EBIT % |
-22.56% |
-22.56% |
-22.56% |
-22.56% |
-22.56% |
-22.56% |
Zysk netto (średni) |
-21.48 |
-4.03 |
3.96 |
23.69 |
43.30 |
64.03 |
Zysk netto % |
-20.54% |
-4.12% |
3.45% |
16.67% |
25.19% |
31.05% |
EPS (średnia) |
-0.47 |
-0.09 |
0.08 |
0.50 |
0.94 |
1.39 |
Liczba analityków (Przychody) |
5 |
7 |
9 |
2 |
1 |
1 |
Liczba analityków (EPS) |
3 |
4 |
4 |
1 |
1 |
1 |
symbol |
BLFS |
BLFS |
BLFS |
BLFS |
BLFS |
BLFS |